NDC 67296-2106
Clindamycin Hydrochloride 300 mg capsule
On the label: RedPharm Drug. Inc.. It's repackaged: RedPharm Drug. Inc. rebottles it from Glenmark Pharmaceuticals Inc., USA's NDC 68462-144.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Glenmark Pharmaceuticals Limited | Dhar, India | Makes it and tests it | Serious problems, FDA actionFeb 14, 2025 · 8 inspections, 1 with FDA action |
Repackaging site
- RedPharm Drug, Eden Prairie, MN, United States · repackages it
Recalls
- Mar 13, 2025 · Class II · Glenmark Pharmaceuticals Inc., USA
CGMP Deviations
Lots: Lot # 17241278, exp. date Jul-26 17241297, exp. date Jul-26 17241304, exp. date Jul-26 17241315, exp. date Jul-26 17241327, exp. date Jul-26
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Clindamycin: every company that makes it
- Form
- capsule
- Strength
- 300 mg
- Approval
- ANDA ANDA216957
- On the market since
- Mar 10, 2023
- Package NDCs
67296-2106-3- Official label
- DailyMed (National Library of Medicine), updated Jul 25, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?